Applied BioMath
Winchester, US · Founded 2013 · Delaware LLC
Find your way into Applied BioMath
Sign up to see every warm intro you have to Applied BioMath
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Applied BioMath team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Applied BioMath (now part of Certara) provides Quantitative Systems Pharmacology (QSP) consulting services that combine computational modeling with experimental data to address drug development challenges such as first-in-human dose selection. Its work spans therapeutic areas including oncology, inflammation and immunology, and neurodegenerative diseases, serving biopharmaceutical drug developers.
Founders & leadership
Applied BioMath was founded in 2013 by John Burke and Joshua Apgar.


Board
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 3 rounds · 2014–2020
▶$25KraisedFeb 2020 · 1 investors · Other Health CareRule 506(b)
- Vihann KongDirector
- John BurkeDirector
- Joshua ApgarDirector
- Andrew SutherlandDirector
- Peter SorgerDirector
- Offering amount
- $4.1M
- Amount sold
- $25K
- Minimum investment
- $25K
- First sale
- Feb 2020
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$505.2KraisedMay 2015 · 20 investors · Other Health CareRule 506(b)
- Andrew SutherlandDirector
- John BurkeDirector
- Joshua ApgarDirector
- Vihann KongDirector
- Peter SorgerDirector
- Offering amount
- $1M
- Amount sold
- $505.2K
- Minimum investment
- $150K
- Proceeds to insiders
- $600K
- First sale
- May 2015
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
▶$930KraisedJan 2014 · 21 investors · Other Health CareRule 506(b)
- John BurkeDirector
- Andrew SutherlandDirector
- Joshua ApgarDirector
- Offering amount
- $1.5M
- Amount sold
- $930K
- Minimum investment
- $10K
- First sale
- Jan 2014
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.5M |
| Food and Drug Administration (FDA)Food and Drug Administration | Phase I | 2019 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $188.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.5M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Applied BioMath do?
- Applied BioMath (now part of Certara) provides Quantitative Systems Pharmacology (QSP) consulting services that combine computational modeling with experimental data to address drug development challenges such as first-in-human dose selection. Its work spans therapeutic areas including oncology, inflammation and immunology, and neurodegenerative diseases, serving biopharmaceutical drug developers.
- Who founded Applied BioMath?
- Applied BioMath was founded by John Burke, Joshua Apgar in 2013.
- How much funding has Applied BioMath raised?
- Applied BioMath has disclosed $1.5M raised across 3 rounds.
- Where is Applied BioMath headquartered?
- Applied BioMath is headquartered in Winchester, US.